The global insulin delivery devices market to showcase a lucrative growth rate during the forecast period. The growth in the market is anticipated due to increased technological advancement in insulin therapy by extensive R&D by major market players of the insulin delivery devices market. At present, scientists and researchers have not been able to found another alternative for curing diabetes. Thus, increased R&D in insulin delivery devices to make them easily accessible to diabetic patients is to drive the growth of the insulin delivery devices industry. The major companies of the insulin delivery devices market are making hefty investments in their R&D department for making new drug approval by the US Food and Drug Administration (FDA).



Get Free Sample Copy @
https://www.omrglobal.com/request-sample/insulin-delivery-devices-market-size



Recent Developments

In February 2019, the US FDA had announced the approval of Tandem Diabetes Care’s t: slim X2 pumps. The t: slim X2 insulin pumps of Tandem Diabetes Care poses several advanced features like a large color touch screen, Bluetooth, rechargeable battery, wireless technology, USB connectivity, and watertight construction. These pumps can make a reliable and secure communication through digitally connected devices such as insulin dosing software, to receive, execute, and confirm command from these devices.

In April 2017, Sanofi and Regeneron Pharmaceuticals, Inc. had received approval of their new supplemental Biologics License Application for a once-monthly 300 mg dose of Praluent Injection for the treatment of adults with high low-density lipoprotein cholesterol. The usage of this supplement will improve glycemic control in adult patients with diabetes. This pen is capable of holding double the quantity of insulin which is previously available. The injectible pen SoloStar and the Max SoloStar are capable of delivering up to 160 units of insulin per injection.

In September 2016, the US FDA announced the approval of Medtronic’s MiniMed 670G system. This device can automatically monitor the blood glucose level of type1 diabetics and delivers appropriate insulin doses to the patient.


Browse for Full Report at:
https://www.omrglobal.com/industry-reports/insulin-delivery-devices-market-size



Current Market Trends Covered in the Market Report

The rapid increase in technological innovation and product development.
North America held a major market share.
Asia-Pacific to show a significant growth rate.
Conferences, meetings, and congresses are to create awareness among people.
Intensive incidence of diabetes across the globe geared the interest of pharmaceutical companies toward diabetes-related R&D.
Partnerships and collaborations – key drivers of competition in this market.


Insulin Delivery Devices Market Segmentation
By Type
Insulin Syringes
Insulin Pens
Insulin Jet Injectors
Insulin Pumps

By End-User Industry
Hospitals & Clinics
Homecare


Insulin Delivery Devices Market – Segment by Region
North America
US
Canada

Europe
Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific
China
Japan
India
Rest of Asia-Pacific

Rest of the World
Middle East & Africa
Latin America


Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/insulin-delivery-devices-market-size


About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404